Back to Rankings

ALKS

AlkermesA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
ALKS vs peer average
79/100
ALKS vs. peer average (A vs. C)
Grade spread
A 3 · B 1 · C 2 · D 5
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

ACAD is the first available peer comparator.

Closest CNS commercial peer for neuropsychiatry execution and specialty-pharma operating discipline; useful for read-through on promotional efficiency and payer traction.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerACADACADIA
ALKS
Alkermes
ACAD
ACADIA
Grade
A
C
Momentum
84
27
Value
65
62
Sentiment
54
75
Setup Bias
Net Bullish
-
Market Cap
-
-
Posture
Constructive
Mixed

Grade position vs ACAD

ALKS / ACAD
Grade Position
Above peers
ALKS vs. peer average (A vs. C)
79/100
Momentum
84
ALKS
Value
65
ALKS
Sentiment
54
ACAD

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ALKS
1
ACAD
ACAD
C
60/100
+2
2
INDV
INDV
A
100/100
Even
3
RYTM
RYTM
D
40/100
+3
4
PCVX
Vaxcyte Inc Common
D
40/100
+3
5
RGEN
Repligen Corp Common
D
40/100
+3
ACAD is the first peer returned for this comparison set.